Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Operating Leases (2019 - 2025)

Perspective Therapeutics (CATX) has disclosed Operating Leases for 7 consecutive years, with $1.0 million as the latest value for Q4 2025.

  • Quarterly Operating Leases fell 29.62% to $1.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Dec 2025, down 29.62% year-over-year, with the annual reading at $1.0 million for FY2025, 29.62% down from the prior year.
  • Operating Leases hit $1.0 million in Q4 2025 for Perspective Therapeutics, up from $971000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $1.7 million in Q3 2024 to a low of $44000.0 in Q1 2023.
  • Historically, Operating Leases has averaged $853894.7 across 5 years, with a median of $838000.0 in 2021.
  • Biggest five-year swings in Operating Leases: crashed 86.42% in 2023 and later soared 2256.82% in 2024.
  • Year by year, Operating Leases stood at $392000.0 in 2021, then increased by 16.84% to $458000.0 in 2022, then surged by 70.31% to $780000.0 in 2023, then skyrocketed by 83.08% to $1.4 million in 2024, then fell by 29.62% to $1.0 million in 2025.
  • Business Quant data shows Operating Leases for CATX at $1.0 million in Q4 2025, $971000.0 in Q3 2025, and $1.1 million in Q2 2025.